Short Interest in Heart Test Laboratories, Inc. (NASDAQ:HSCS) Increases By 6.1%

Heart Test Laboratories, Inc. (NASDAQ:HSCS) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 31,200 shares, a growth of 6.1% from the December 15th total of 29,400 shares. Approximately 3.8% of the company’s stock are short sold. Based on an average daily trading volume, of 42,900 shares, the short-interest ratio is presently 0.7 days.

Analyst Upgrades and Downgrades

HSCS has been the topic of a number of research analyst reports. Ascendiant Capital Markets reiterated a “buy” rating and set a $15.00 target price on shares of Heart Test Laboratories in a report on Monday, September 23rd. Maxim Group reaffirmed a “buy” rating and issued a $12.00 price target on shares of Heart Test Laboratories in a research note on Wednesday, December 18th.

Heart Test Laboratories Trading Up 4.2 %

NASDAQ:HSCS opened at $3.47 on Tuesday. The firm has a market capitalization of $3.40 million, a P/E ratio of -0.44 and a beta of 2.90. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.52. Heart Test Laboratories has a one year low of $2.36 and a one year high of $18.50. The company’s 50-day simple moving average is $3.43 and its 200 day simple moving average is $3.51.

Heart Test Laboratories (NASDAQ:HSCS) last released its earnings results on Monday, December 16th. The company reported ($2.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.30) by $0.03. During the same quarter in the previous year, the business earned ($15.92) EPS. As a group, analysts forecast that Heart Test Laboratories will post -9.82 EPS for the current fiscal year.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.